Tags

Type your tag names separated by a space and hit enter

The Use of "Novel Pharmacology" in the Treatment of COVID-19 and Potential Psychiatric Risks.
Prim Care Companion CNS Disord. 2020 05 21; 22(3)PC

Authors+Show Affiliations

Waltham Forest Mental Health Team, North East London Foundation Trust, Red Oak Lodge, London, England E11 4HU. a.yahya@nhs.net.No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32441496

Citation

Yahya, Ahmed Saeed, et al. "The Use of "Novel Pharmacology" in the Treatment of COVID-19 and Potential Psychiatric Risks." The Primary Care Companion for CNS Disorders, vol. 22, no. 3, 2020.
Yahya AS, Khawaja S, Chukwuma J. The Use of "Novel Pharmacology" in the Treatment of COVID-19 and Potential Psychiatric Risks. Prim Care Companion CNS Disord. 2020;22(3).
Yahya, A. S., Khawaja, S., & Chukwuma, J. (2020). The Use of "Novel Pharmacology" in the Treatment of COVID-19 and Potential Psychiatric Risks. The Primary Care Companion for CNS Disorders, 22(3). https://doi.org/10.4088/PCC.20com02638
Yahya AS, Khawaja S, Chukwuma J. The Use of "Novel Pharmacology" in the Treatment of COVID-19 and Potential Psychiatric Risks. Prim Care Companion CNS Disord. 2020 05 21;22(3) PubMed PMID: 32441496.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The Use of "Novel Pharmacology" in the Treatment of COVID-19 and Potential Psychiatric Risks. AU - Yahya,Ahmed Saeed, AU - Khawaja,Shakil, AU - Chukwuma,Jude, Y1 - 2020/05/21/ PY - 2020/5/23/entrez PY - 2020/5/23/pubmed PY - 2020/6/6/medline JF - The primary care companion for CNS disorders JO - Prim Care Companion CNS Disord VL - 22 IS - 3 SN - 2155-7780 UR - https://www.unboundmedicine.com/medline/citation/32441496/The_Use_of_"Novel_Pharmacology"_in_the_Treatment_of_COVID_19_and_Potential_Psychiatric_Risks_ L2 - http://www.psychiatrist.com/pcc/article/pages/potential-psychiatric-risks-of-novel-covid-treatments.aspx DB - PRIME DP - Unbound Medicine ER -